v3.24.0.1
Organization, Business and Basis of Presentation - Additional Information (Detail)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Feb. 28, 2023
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
Segment
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
Description Of Business [Line Items]          
Accumulated deficit     $ (468,023) $ (417,634)  
Cash equivalents, available-for-sale investments and restricted cash     101,700    
Restricted cash     $ 3,484 $ 3,165 $ 0
Number of operating segment | Segment     1    
Public Offerings [Member]          
Description Of Business [Line Items]          
Proceeds from Issuance of Common Stock $ 48,100 $ 80,600      
Public Offerings [Member] | Common Stock [Member]          
Description Of Business [Line Items]          
Number of shares issued and sold | shares 23,125,000 10,781,250      
Shares Issued, Price Per Share | $ / shares $ 2.25 $ 8      
ATM Offering Program [Member] | Jefferies LLC [Member]          
Description Of Business [Line Items]          
Shares Issued, Price Per Share | $ / shares     $ 1.82 $ 3.09  
Proceeds from Issuance of Common Stock     $ 18,400 $ 4,000  
ATM Offering Program [Member] | Common Stock [Member] | Jefferies LLC [Member]          
Description Of Business [Line Items]          
Number of shares issued and sold | shares     10,530,795 1,421,627  
Pangu BioPharma [Member] | Hong Kong [Member]          
Description Of Business [Line Items]          
Majority-owned subsidiary percentage     98.00%